Journal of Endocrinology and Metabolism

Editor-in-Chief
Hidekatsu Yanai, MD, National Center for Global Health and Medicine, Chiba, Japan

Frequency: Bimonthly
Journal access: Open Access
ISSN-print: 1923-2861
ISSN-online: 1923-287X
Indexed and covered by: Scopus, Chemical Abstract (CA); EBSCO; Worldcat; Google Scholar; Google; JournalTOCs; PubMed: selected citations only (NIH supported articles); Clarivate Analytics Emerging Sources Citation Index (ESCI-Web of Science)
Journal archiving and digital preservation: Portico

 

Combat the COVID-19

Let's Combat COVID-19 Pandemic Together
 The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and health care providers. The Elmer Press Inc is herein to participate the combating COVID-19 through all possible efforts, as a clinical medicine publisher, we would facilitate the rapid and effective communication of management of this pandemic, we will consider submissions related to all aspects of this disease, including prevention, basic viral research, epidemiology, treatment, vaccine, fast screening, diagnosis, prognosis, etc. We will process such manuscripts in priority and publish them ASAP after peer-reviewed and accepted.


Highlights

  • Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Hepatic Fibrosis in Patients With Type 2 Diabetes: A Chart-Based Analysis

    The presence of nonalcoholic fatty liver diseases (NAFLDs) and type 2 diabetes was associated with elevated risks of cardiovascular events as well as the progression of NAFLD to fibrosis/cirrhosis and hepatocellular carcinoma.

    Read More >>
  • Effects of Policosanol in Patients With Metabolic Syndrome: A Six-Month Study

    The metabolic syndrome comprises a set of cardiovascular risk factors represented by obesity of central distribution, dyslipidemias, glucose metabolism abnormalities and arterial hypertension, closely associated with insulin resistance. The aim of this study is to investigate in the medium term the effects of policosanol in patients with metabolic syndrome, as well as its safety and tolerability.

    Read More >>
  • Acute Pancreatitis in a Patient With Parathyroid Carcinoma

    Parathyroid carcinoma is a rare endocrine malignancy. Clinical features of parathyroid carcinoma are mainly due to the effects of primary hyperparathyroidism (PHPT). Hypercalcemia produced by primary or secondary hyperparathyroidism is a rare and unclear cause of acute pancreatitis.

    Read More >>
  • Evaluation of Age-Specific Efficacy and Safety of 12 Months of Sitagliptin Therapy Administered by Non-Diabetologists

    The efficacy and safety of sitagliptin therapy in the elderly were confirmed in non-specialist settings. These findings will help non-diabetologists choose an appropriate drug in areas where the numbers of diabetic patients and elderly persons are increasing.

    Read More >>
  • The Effects of Teneligliptin on Lipid Profile: A Prospective Study for Comparison of Biomarkers Before and After a Meal

    In the treatment of diabetes mellitus, it is important to prevent dyslipidemia, which is one of the complications. However, no study has examined the long-term effects of teneligliptin on the blood parameters of apolipoprotein B (apoB) after a meal in patients with type 2 diabetes.

    Read More >>
< >

Viewpoints

 

 

Featured

 

The Points of Action of Drugs for Treating COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has reached a pandemic level. Very recently, I reported a significantly higher prevalence of diabetes and hypertension in severe COVID-19 as compared with non-severe COVID-19 by the meta-analysis. Full Text

Sodium-Glucose Co-Transporter 2 Inhibitors Increase Serum Level of Total Procollagen Type 1 Amino-Terminal Propeptide and Bone Strength in Japanese Patients With Type 2 Diabetes Mellitus

Diabetes mellitus is known to be associated with an increased risk of bone fracture. We investigated the effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on bone strength and density in type 2 diabetic patients. Full Text


Image of the Issue

 

Multiple Brown Tumors Caused by Primary Hyperparathyroidism as a Differential Diagnosis to Multiple Osteolytic Bone Metastases
 Brown tumors are benign osteolytic lesions, which usually respect the bone cortex. Since these lesions may resemble bone metastases, it is important to consider them as a potential differential diagnosis. They occur as a result of increased parathyroid hormone (PTH) secretion mainly due to primary or secondary hyperparathyroidism. Full Text


Current Issue

 


Vol. 10, No. 5, Oct 2020

Table of Contents

Review

An Appropriate Energy Intake Proportion of Three Major Nutrients for Treatment of Type 2 Diabetes Abstract HTML PDF
Hidekatsu Yanai, Hisayuki Katsuyama 113-117
doi: https://doi.org/10.14740/jem693

Original Article

Association of Diabetes and Severe COVID-19 Outcomes: A Rapid Review and Meta-Analysis Abstract HTML PDF Suppl1
Mmamapudi Kubjane, Nicole McCreedy, Bertrand Cariou, Miguel A. Rubio, Ulrik Haagen Panton, Christian Hvid, Nadilka Hettiarachchige, Helen Mearns 118-130
doi: https://doi.org/10.14740/jem698
Effects of Self-Awareness of Eating Behaviors and Differences in Daily Habits Among Japanese University Students on Changes in Weight and Metabolism Abstract HTML PDF Suppl1
Tetsuya Kakuma, Yuichi Yoshida, Mitsuhiro Okamoto, Hirotaka Shibata, Takashi Tsutsumi, Yoshikuni Kudo 131-139
doi: https://doi.org/10.14740/jem687

Case Report

Difficulties in Correction of Recurrent Hypoglycemia in a Patient With a Progressive Course of Malignant Metastatic Insulinoma Abstract HTML PDF
Oksana V. Tsygankova, Antonina G. Antipenko, Natalia E. Evdokimova, Ludmila D. Latyntseva, Sabina S. Bairamova, Tatiana I. Batluk 140-143
doi: https://doi.org/10.14740/jem666
Adrenal Insufficiency due to Total Primary Empty Sella Syndrome Abstract HTML PDF
Daisuke Usuda, Susumu Takagi, Kohei Takanaga, Toshihide Izumida, Ryusho Sangen, Toshihiro Higashikawa, Yuji Kasamaki 144-153
doi: https://doi.org/10.14740/jem686
　

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.